Global measurement of proteins and their many attributes in tissues and biofluids defines the field of proteomics. Toxicoproteomics, as part of the larger field of toxicogenomics, seeks to identify critical proteins and pathways in biological systems that are affected by and respond to adverse chemical and environmental exposures using global protein expression technologies. Toxicoproteomics integrates 3 disciplinary areas: traditional toxicology and pathology, differential protein and gene expression analysis, and systems biology. Key topics to be reviewed are the evolution of proteomics, proteomic technology platforms and their capabilities with exemplary studies from biology and medicine, a review of over 50 recent studies applying proteomic analysis to toxicological research, and the recent development of databases designed to integrate -Omics technologies with toxicology and pathology. Proteomics is examined for its potential in discovery of new biomarkers and toxicity signatures, in mapping serum, plasma, and other biofluid proteomes, and in parallel proteomic and transcriptomic studies. The new field of toxicoproteomics is uniquely positioned toward an expanded understanding of protein expression during toxicity and environmental disease for the advancement of public health.
Abe, T., Kanaya, S., Kinouchi, M., Ichiba, Y., Kozuki, T., and Ikemura, T. (2003). Informatics for unveiling hidden genome signatures . Genome Res13, 693—702.
2.
Adkins, J.N., Varnum, S.M., Auberry, K.J., Moore, R.J., Angell, N.H., Smith, R.D., Springer, D.L., and Pounds, J.G. (2002). Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics1, 947—55.
3.
Agrawal, G.K., Rakwal, R., Yonekura, M., Kubo, A., and Saji, H. (2002). Proteome analysis of differentially displayed proteins as atool for investigating ozone stress in rice (Oryza sativa L.) seedlings. Proteomics2, 947—59.
4.
Ahn, N.G., and Resing, K.A. (2001). Toward the phosphoproteome. Nat Biotechnol19, 317—8.
5.
Amacher, D.E. (2002). A toxicologist's guide to biomarkers of hepatic response. Hum Exp Toxicol21, 253—62.
6.
Andersen, J.S., Lyon, C.E., Fox, A.H., Leung, A.K., Lam, Y.W., Steen, H., Mann, M., and Lamond, A.I. (2002). Directed proteomic analysis of the human nucleolus . Curr Biol12, 1—11.
7.
Anderson, N.L., and Anderson, N.G. (2002). The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics1, 845— 67.
8.
Apweiler, R., Bairoch, A., Wu, C.H., Barker, W.C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M.J., Natale, D.A., O'Donovan, C., Redaschi, N., and Yeh, L.S. (2004). UniProt: the Universal Protein knowledgebase. Nucleic Acids Res32(Database issue), D115—9.
9.
Arcellana-Panlilio, M., and Robbins, S.M. (2002). Cutting-edge technology. I. Global gene expression profiling using DNA microarrays. Am J Physiol Gastrointest Liver Physiol282, G397—402.
10.
Bacarese-Hamilton, T., Ardizzoni, A., Gray, J., and Crisanti, A. (2004). Protein arrays for serodiagnosis of disease. Methods Mol Biol278, 271—84.
11.
Badghisi, H., and Liebler, D.C. (2002). Sequence mapping of epoxide adducts in human hemoglobin with LC-tandem MS and the SALSA algorithm. Chem Res Toxicol15, 799—805.
12.
Bailey, W.J., and Ulrich, R. (2004). Molecular profiling approaches for identifying novel biomarkers. Expert Opin Drug Saf3, 137—51.
13.
Bajzer, Z., Randic, M., Plavsic, D., and Basak, S.C. (2003). Novel map descriptors for characterization of toxic effects in proteomics maps. J Mol Graph Model22, 1—9.
14.
Bandara, L.R., Kelly, M.D., Lock, E.A., and Kennedy, S. (2003a). A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicol Sci73, 195— 206.
15.
Bandara, L.R., Kelly, M.D., Lock, E.A., and Kennedy, S. (2003b). A potential biomarker of kidney damage identified by proteomics: preliminary findings. Biomarkers8, 272—86.
16.
Benard, J., Douc-Rasy, S., and Ahomadegbe, J.C. (2003). TP53 family members and human cancers. Hum Mutat21, 182—91.
17.
Bergmann, S., Ihmels, J., and Barkai, N. (2003). Iterative signature algorithm for the analysis of large-scale gene expression dataPhys Rev E Stat Nonlin Soft Matter Phys67, 031902.
18.
Bischoff, R., and Luider, T.M. (2004). Methodological advances in the discovery of protein and peptide disease markers. J Chromatogr B Analyt Technol Biomed Life Sci803, 27—40.
19.
Boorman, G.A., Anderson, S.P., Casey, W.M., Brown, R.H., Crosby, L.M., Gottschalk, K., Easton, M., Ni, H., and Morgan, K.T. (2002). Toxicogenomics, drug discovery, and the pathologist . Toxicol Pathol30, 15—27.
20.
Braga, P.C., and Ricci, D. (2004). Atomic Force Microscopy: Biomedical Methods and Applications. Humana Press, Totowa, NJ.
21.
Bratton, S.B., and Cohen, G.M. (2003). Death receptors leave a caspase footprint that Smacs of XIAP. Cell Death Differ10, 4—6.
22.
Brazma, A., Parkinson, H., Sarkans, U., Shojatalab, M., Vilo, J., Abeygunawardena, N., Holloway, E., Kapushesky, M., Kemmeren, P., Lara, G.G., Oezcimen, A., Rocca-Serra, P., and Sansone, S.A. (2003). ArrayExpress—a public repository for microarray gene expression data at the EBI. Nucleic Acids Res31, 68—71.
23.
Bruno, M.E., Borchers, C.H., Dial, J.M., Walker, N.J., Hartis, J.E., Wetmore, B.A., Carl Barrett, J.C., Tomer, K.B., and Merrick, B.A. (2002). Effects of TCDD upon IkappaB and IKK subunits localized in microsomes by proteomics. Arch Biochem Biophys406, 153—64.
24.
Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D.F., and Sanchez, J.C. (2003). A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics3, 1486—94.
25.
Cash, P., and Kroll, J.S. (2003). Protein characterization by two-dimensional gel electrophoresis. Methods Mol Med71, 101—18.
26.
Castegna, A., Thongboonkerd, V., Klein, J.B., Lynn, B., Markesbery, W.R., and Butterfield, D.A. (2003). Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem85, 1394—401.
27.
Celis, J.E., Gesser, B., Dejgaard, K., Honore, B., Leffers, H., Madsen, P., Andersen, A., Basse, B., Celis, A., Lauridsen, J.B., Ratz, G.P., Bauw, G., van Damme, J., Puype, M., Van den Bulcke, M., and Vandekere Khove, J. (1989). Two dimensional gel human protein databases offer a systematic approach to the study of cell proliferation and differentiation. Int J Dev Biol33, 407—16.
28.
Charlwood, J., Skehel, J.M., King, N., Camilleri, P., Lord, P., Bugelski, P., and Atif, U. (2002). Proteomic analysis of rat kidney cortex following treatment with gentamicin. J Proteome Res1, 73—82.
29.
Choe, L.H., Dutt, M.J., Relkin, N., and Lee, K.H. (2002). Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease. Electrophoresis23, 2247—51.
30.
Conrads, T.P., Fusaro, V.A., Ross, S., Johann, D., Rajapakse, V., Hitt, B.A., Steinberg, S.M., Kohn, E.C., Fishman, D.A., Whitely, G., Barrett, J.C., Liotta, L.A., Petricoin, I.E., and Veenstra, T.D. (2004). High-resolution serum proteomic features for ovarian cancer detection. Endocr Relat Cancer11, 163—78.
31.
Cordwell, S.J., Nouwens, A.S., Verrills, N.M., Basseal, D.J., and Walsh, B.J. (2000). Subproteomics based upon protein cellular location and relative solubilities in conjunction with composite two-dimensional electrophoresis gels. Electrophoresis21, 1094—103.
32.
Courtois, S., de Fromentel, C.C., and Hainaut, P. (2004). p53 protein variants: structural and functional similarities with p63 and p73 isoforms. Oncogene23, 631—8.
33.
Cristoni, S., and Bernardi, L.R. (2003). Development of new methodologies for the mass spectrometry study of bioorganic macromolecules. Mass Spectrom Rev22, 369—406.
34.
Cutler, P. (2003). Protein arrays: the current state-of-the-art. Proteomics3, 3—18.
35.
Cutler, P., Bell, D.J., Birrell, H.C., Connelly, J.C., Connor, S.C., Holmes, E., Mitchell, B.C., Monte, S.Y., Neville, B.A., Pickford, R., Polley, S., Schneider, K., and Skehel, J.M. (1999). An integrated proteomic approach to studying glomerular nephrotoxicity. Electrophoresis20, 3647—58.
36.
Dapas, B., Tell, G., Scaloni, A., Pines, A., Ferrara, L., Quadrifoglio, F., and Scaggiante, B. (2003). Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Eur J Biochem270, 3251— 62.
37.
Dare, T.O., Davies, H.A., Turton, J.A., Lomas, L., Williams, T.C., and York, M.J. (2002). Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbuminalpha: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis23, 3241—51.
38.
Davis, T.N. (2004). Protein localization in proteomics. Curr Opin Chem Biol8, 49—53.
39.
Demonacos, C., and La Thangue, N.B. (2003). Drug discovery and the p53 family. Prog Cell Cycle Res5, 375—82.
40.
Diamandis, E.P. (2004). Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics3, 367—78.
41.
Dongre, A.R., Opiteck, G., Cosand, W.L., and Hefta, S.A. (2001). Proteomics in the post-genome age. Biopolymers60, 206—11.
42.
Drake, M.G., Witzmann, F.A., Hyde, J., and Witten, M.L. (2003). JP-8 jet fuel exposure alters protein expression in the lung. Toxicology191, 199—210.
43.
Dreger, M. (2003). Subcellular proteomics. Mass Spectrom Rev22, 27—56.
44.
Duan, X.J., Xenarios, I., and Eisenberg, D. (2002). Describing biological protein interactions in terms of protein states and state transitions: the LiveDIP database. Mol Cell Proteomics1, 104—16.
45.
Fennell, T.R., Snyder, R.W., Krol, W.L., and Sumner, S.C. (2003). Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol Sci71, 164—75.
46.
Fessler, M.B., Malcolm, K.C., Duncan, M.W., and Worthen, G.S. (2002). A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem277, 31291—302.
47.
Fountoulakis, M., Berndt, P., Boelsterli, U.A., Crameri, F., Winter, M., Albertini, S., and Suter, L. (2000). Two-dimensional database of mouse liverproteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis21, 2148— 61.
48.
Frank, R., and Hargreaves, R. (2003). Clinical biomarkers in drug discovery and development . Nat Rev Drug Discov2, 566—80.
49.
Gao, J., Ann Garulacan, L., Storm, S.M., Hefta, S.A., Opiteck, G.J., Lin, J.H., Moulin, F., and Dambach, D.M. (2004). Identification of in vitro protein biomarkers of idiosyncratic liver toxicity. Toxicol In Vitro18, 533— 41.
50.
Geschwind, D.H. (2003). DNA microarrays: translation of the genome from laboratory to clinic. Lancet Neurol2, 275—82.
51.
Gorg, A., and Weiss, W. (1999). Analytical IPG-Dalt. Methods Mol Biol112, 189—95.
52.
Goshe, M.B., Veenstra, T.D., Panisko, E.A., Conrads, T.P., Angell, N.H., and Smith, R.D. (2002). Phosphoprotein isotope-coded affinity tags: application to the enrichment and identification of low-abundance phosphoproteins. Anal Chem74, 607—16.
53.
Graves, P.R., and Haystead, T.A. (2003). A functional proteomics approach to signal transduction . Recent Prog Horm Res58, 1—24.
54.
Griffin, T.J., Gygi, S.P., Ideker, T., Rist, B., Eng, J., Hood, L., and Aebersold, R. (2002). Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics1, 323—33.
55.
Guerreiro, N., Staedtler, F., Grenet, O., Kehren, J., and Chibout, S.D. (2003). Toxicogenomics in drug development. Toxicol Pathol31, 471—9.
Gygi, S.P., Rist, B., Gerber, S.A., Turecek, F., Gelb, M.H., and Aebersold, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol17, 994—9.
58.
Hanash, S. (2003). Disease proteomics. Nature422, 226—32.
59.
Hansen, K.C., Schmitt-Ulms, G., Chalkley, R.J., Hirsch, J., Baldwin, M.A., and Burlingame, A.L. (2003). Mass spectrometric analysis of protein mixtures at low levels using cleavable 13C-isotope-coded affinity tag and multidimensional chromatography. Mol Cell Proteomics2, 299—314.
60.
Harrison, P.M., Kumar, A., Lang, N., Snyder, M., and Gerstein, M. (2002). A question of size: the eukaryotic proteome and the problems in defining it. Nucleic Acids Res30, 1083—90.
61.
Heijne, W.H., Stierum, R.H., Slijper, M., van Bladeren, P.J., and van Ommen, B. (2003). Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem Pharmacol65, 857— 75.
62.
Herbert, A. (2004). The four Rs of RNA-directed evolution. Nat Genet36, 19— 25.
63.
Hermjakob, H., Montecchi-Palazzi, L., Bader, G., Wojcik, J., Salwinski, L., Ceol, A., Moore, S., Orchard, S., Sarkans, U., von Mering, C., Roechert, B., Poux, S., Jung, E., Mersch, H., Kersey, P., Lappe, M., Li, Y., Zeng, R., Rana, D., Nikolski, M., Husi, H., Brun, C., Shanker, K., Grant, S.G., Sander, C., Bork, P., Zhu, W., Pandey, A., Brazma, A., Jacq, B., Vidal, M., Sherman, D., Legrain, P., Cesareni, G., Xenarios, I., Eisenberg, D., Steipe, B., Hogue, C., and Apweiler, R. (2004). The HUPO PSI's molecular interaction format—a community standard for the representation of protein interaction data. Nat Biotechnol22, 177—83.
64.
Hestvik, A.L., Hmama, Z., and Av-Gay, Y. (2003). Kinome analysis of host response to mycobacterial infection: a novel technique in proteomics. Infect Immun71, 5514—22.
65.
Hirata, A., Masuda, S., Tamura, T., Kai, K., Ojima, K., Fukase, A., Motoyoshi, K., Kamakura, K., Miyagoe-Suzuki, Y., and Takeda, S. (2003). Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am J Pathol163, 203— 15.
66.
Hogstrand, C., Balesaria, S., and Glover, C.N. (2002). Application of genomics and proteomics for study of the integrated response to zinc exposure in a non-model fish species, the rainbow trout. Comp Biochem Physiol B Biochem Mol Biol133, 523—35.
67.
Hu, Y., Hines, L.M., Weng, H., Zuo, D., Rivera, M., Richardson, A., and LaBaer, J. (2003). Analysis of genomic and proteomic data using advanced literature mining. J Proteome Res2, 405—12.
68.
Huang, R., Lin, Y., Wang, C.C., Gano, J., Lin, B., Shi, Q., Boynton, A., Burke, J., and Huang, R.P. (2002). Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res62, 2806— 12.
69.
Huang, R.P. (2003). Protein arrays, an excellent tool in biomedical research. Front Biosci8, d559—76.
70.
Ideker, T., Galitski, T., and Hood, L. (2001a). A new approach to decoding life: systems biology . Annu Rev Genomics Hum Genet2, 343—72.
71.
Ideker, T., Thorsson, V., Ranish, J.A., Christmas, R., Buhler, J., Eng, J.K., Bumgarner, R., Goodlett, D.R., Aebersold, R., and Hood, L. (2001b). Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science292, 929—34.
72.
Iida, M., Anna, C.H., Hartis, J., Bruno, M., Wetmore, B., Dubin, J.R., Sieber, S., Bennett, L., Cunningham, M.L., Paules, R.S., Tomer, K.B., Houle, C.D., Merrick, A.B., Sills, R.C., and Devereux, T.R. (2003). Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis24, 757—70.
73.
Imanishi, S., and Harada, K. (2004). Proteomics approach on microcystin binding proteins in mouse liver for investigation of microcystin toxicity. Toxicon43, 651—9.
74.
Ishkanian, A.S., Malloff, C.A., Watson, S.K., DeLeeuw, R.J., Chi, B., Coe, B.P., Snijders, A., Albertson, D.G., Pinkel, D., Marra, M.A., Ling, V., MacAulay, C., and Lam, W.L. (2004). A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet36, 299—303.
75.
Issaq, H.J., Conrads, T.P., Prieto, D.A., Tirumalai, R., and Veenstra, T.D. (2003). SELDI-TOF MS for diagnostic proteomics. Anal Chem75, 148A— 155A.
76.
Ivanov, S.S., Chung, A.S., Yuan, P.Z., Guan, A.Y., Sachs, K.V., Reichner, J.S., and Chin, Y.E. (2004). Antibodies immobilized as arrays to profile protein post-translational modifications in mammalian cells. Mol Cell Proteomics, in press.
77.
Izzotti, A., Bagnasco, M., Cartiglia, C., Longobardi, M., and De Flora, S. (2004). Proteomic analysis as related to transcriptome data in the lung of chromium(VI)-treated rats. Int J Oncol24, 1513—22.
78.
Jiang, L., Lindpaintner, K., Li, H.F., Gu, N.F., Langen, H., He, L., and Fountoulakis, M. (2003). Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids25, 49—57.
79.
Jin, J., Yang, J., Gao, Z., and Yu, Y. (2004). Proteomic analysis of cellular responses to low concentration N-methyl-N'-nitro-N-nitrosoguanidine in human amnion FL cells . Environ Mol Mutagen43, 93—9.
80.
Jones, A., Hunt, E., Wastling, J., Pizarro, A., and Stoeckert, C.J., Jr. (2004). An object model and database for functional genomicsBioinformatics, in press.
81.
Ju, C., and Pohl, L.R. (2001). Immunohistochemical detection of protein adducts of 2,4-dinitrochlorobenzene in antigen presenting cells and lymphocytes after oral administration to mice: lack of a role of Kupffer cells in oral tolerance . Chem Res Toxicol14, 1209—17.
82.
Ju, C., and Uetrecht, J.P. (2002). Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system . Curr Drug Metab3, 367—77.
83.
Keightley, J.A., Shang, L., and Kinter, M. (2004). Proteomic analysis of oxidative stress-resistant cells: a specific role for aldose reductase overexpression in cytoprotection . Mol Cell Proteomics3, 167—75.
84.
Kennedy, S. (2001). Proteomic profiling from human samples: the body fluid alternative. Toxicol Lett120, 379—84.
85.
Kennedy, S. (2002). The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression studies. Biomarkers7, 269— 90.
86.
Kern, W., Kohlmann, A., Wuchter, C., Schnittger, S., Schoch, C., Mergenthaler, S., Ratei, R., Ludwig, W.D., Hiddemann, W., and Haferlach, T. (2003). Correlation of protein expression and gene expression in acute leukemia. Cytometry55B, 29—36.
87.
Kidd, D., Liu, Y., and Cravatt, B.F. (2001). Profiling serine hydrolase activities in complex proteomes. Biochemistry40, 4005—15.
88.
Kleno, T.G., Leonardsen, L.R., Kjeldal, H.O., Laursen, S.M., Jensen, O.N., and Baunsgaard, D. (2004). Mechanisms of hydrazine toxicity in rat liver investigated by proteomics and multivariate data analysis. Proteomics4, 868—80.
89.
Klose, J. (1975). Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik26, 231—43.
90.
Koga, H., Shimada, K., Hara, Y., Nagano, M., Kohga, H., Yokoyama, R., Kimura, Y., Yuasa, S., Magae, J., Inamoto, S., Okazaki, N., and Ohara, O. (2004). A comprehensive approach for establishment of the platform to analyze functions of KIAA proteins: generation and evaluation of anti-mKIAA antibodies. Proteomics4, 1412—6.
91.
Koopmann, J., Zhang, Z., White, N., Rosenzweig, J., Fedarko, N., Jagannath, S., Canto, M.I., Yeo, C.J., Chan, D.W., and Goggins, M. (2004). Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res10, 860—8.
92.
Krapfenbauer, K., Berger, M., Lubec, G., and Fountoulakis, M. (2001). Changes in the brain protein levels following administration of kainic acid. Electrophoresis22, 2086—91.
93.
Krayl, M., Benndorf, D., Loffhagen, N., and Babel, W. (2003). Use of proteomics and physiological characteristics to elucidate ecotoxic effects of methyl tert-butyl ether in Pseudomonas putida KT2440. Proteomics3, 1544—52.
94.
Kristensen, D.B., Kawada, N., Imamura, K., Miyamoto, Y., Tateno, C., Seki, S., Kuroki, T., and Yoshizato, K. (2000). Proteome analysis of rat hepatic stellate cells . Hepatology32, 268—77.
95.
Kusnezow, W., and Hoheisel, J.D. (2002). Antibody microarrays: promises and problemsBiotechniques (Suppl), 14—23.
96.
Lame, M.W., Jones, A.D., Wilson, D.W., and Segall, H.J. (2003). Protein targets of 1,4-benzoquinone and 1,4-naphthoquinone in human bronchial epithelial cellsProteomics3, 479—95.
97.
Lauber, W.M., Carroll, J.A., Dufield, D.R., Kiesel, J.R., Radabaugh, M.R., and Malone, J.P. (2001). Mass spectrometry compatibility of two-dimensional gel protein stains. Electrophoresis22, 906—18.
98.
Lee, C.L., Hsiao, H.H., Lin, C.W., Wu, S.P., Huang, S.Y., Wu, C.Y., Wang, A.H., and Khoo, K.H. (2003a). Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines. Proteomics3, 2472—86.
99.
Lee, Y.M., Park, S.H., Chung, K.C., and Oh, Y.J. (2003b). Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine . Neurosci Lett352, 17—20.
100.
Li, J., White, N., Zhang, Z., Rosenzweig, J., Mangold, L.A., Partin, A.W., and Chan, D.W. (2004). Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. J Urol171, 1782—7.
Link, A.J., Eng, J., Schieltz, D.M., Carmack, E., Mize, G.J., Morris, D.R., Garvik, B.M., and Yates, J.R., 3rd. (1999). Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol17, 676—82.
103.
Lion, N., Rohner, T.C., Dayon, L., Arnaud, I.L., Damoc, E., Youhnovski, N., Wu, Z.Y., Roussel, C., Josserand, J., Jensen, H., Rossier, J.S., Przybylski, M., and Girault, H.H. (2003). Microfluidic systems in proteomics. Electrophoresis24, 3533—62.
104.
Liotta, L.A., Ferrari, M., and Petricoin, E. (2003). Clinical proteomics: written in blood. Nature425, 905.
105.
Liu, Z.X., and Kaplowitz, N. (2002). Immune-mediated drug-induced liver disease. Clin Liver Dis6, 467—86.
106.
Lue, R.Y., Chen, G.Y., Zhu, Q., Lesaicherre, M.L., and Yao, S.Q. (2004). Sitespecific immobilization of biotinylated proteins for protein microarray analysis. Methods Mol Biol278, 85—100.
107.
MacCoss, M.J., McDonald, W.H., Saraf, A., Sadygov, R., Clark, J.M., Tasto, J.J., Gould, K.L., Wolters, D., Washburn, M., Weiss, A., Clark, J.I., and Yates, J.R., 3rd. (2002). Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci USA99, 7900— 5.
108.
Macdonald, N., Chevalier, S., Tonge, R., Davison, M., Rowlinson, R., Young, J., Rayner, S., and Roberts, R. (2001). Quantitative proteomic analysis of mouse liver response to the peroxisome proliferator diethylhexylphthalate (DEHP). Arch Toxicol75, 415—24.
109.
Man, W.J., White, I.R., Bryant, D., Bugelski, P., Camilleri, P., Cutler, P., Heald, G., Lord, P.G., Wood, J., and Kramer, K. (2002). Protein expression analysis of drug-mediated hepatotoxicity in the Sprague—Dawley rat. Proteomics2, 1577—85.
110.
Mann, M., Hendrickson, R.C., and Pandey, A. (2001). Analysis of proteins and proteomes by mass spectrometry . Annu Rev Biochem70, 437—73.
111.
Mannes, A.J., Martin, B.M., Yang, H.Y., Keller, J.M., Lewin, S., Gaiser, R.R., and Iadarola, M.J. (2003). Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain102, 251—6.
112.
Marengo, E., Robotti, E., Gianotti, V., Righetti, P.G., Cecconi, D., and Domenici, E. (2003). A new integrated statistical approach to the diagnostic use of two-dimensional maps. Electrophoresis24, 225—36.
113.
Maunsbach, A., and Afzelium, B. (1999). Biomedical Electron Microscopy: Illustrated Methods and Interpretations. Academic Press, San Diego, CA.
114.
McDonald, W.H., and Yates, J.R., 3rd. (2003). Shotgun proteomics: integrating technologies to answer biological questionsCurrOpinMol Ther5, 302—9.
115.
McPherson, J.D., Marra, M., Hillier, L., Waterston, R.H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., Mardis, E.R., Wilson, R.K., Fulton, R., Kucaba, T.A., Wagner-McPherson, C., Barbazuk, W.B., Gregory, S.G., Humphray, S.J., French, L., Evans, R.S., Bethel, G., Whittaker, A., Holden, J.L., McCann, O.T., Dunham, A., Soderlund, C., Scott, C.E., Bentley, D.R., Schuler, G., Chen, H.C., Jang, W., Green, E.D., Idol, J.R., Maduro, V.V., Montgomery, K.T., Lee, E., Miller, A., Emerling, S., Kucherlapati, Gibbs,R., Scherer, S., Gorrell, J.H., Sodergren, E., Clerc-Blankenburg, K., Tabor, P., Naylor, S., Garcia, D., de Jong, P.J., Catanese, J.J., Nowak, N., Osoegawa, K., Qin, S., Rowen, L., Madan, A., Dors, M., Hood, L., Trask, B., Friedman, C., Massa, H., Cheung, V.G., Kirsch, I.R., Reid, T., Yonescu, R., Weissenbach, J., Bruls, T., Heilig, R., Branscomb, E., Olsen, A., Doggett, N., Cheng, J.F., Hawkins, T., Myers, R.M., Shang, J., Ramirez, L., Schmutz, J., Velasquez, O., Dixon, K., Stone, N.E., Cox, D.R., Haussler, D., Kent, W.J., Furey, T., Rogic, S., Kennedy, S., Jones, S., Rosenthal, A., Wen, G., Schilhabel, M., Gloeckner, G., Nyakatura, G., Siebert, R., Schlegelberger, B., Korenberg, J., Chen, X.N., Fujiyama, A., Hattori, M., Toyoda, A., Yada, T., Park, H.S., Sakaki, Y., Shimizu, N., Asakawa, S., Kawasaki, K., Sasaki, T., Shintani, A., Shimizu, A., Shibuya, K., Kudoh, J., Minoshima, S., Ramser, J., Seranski, P., Hoff, C., Poustka, A., Reinhardt, R., and Lehrach, H. (2001). A physical map of the human genome. Nature409, 934—41.
116.
McRedmond, J.P., Park, S.D., Reilly, D.F., Coppinger, J.A., Maguire, P.B., Shields, D.C., and Fitzgerald, D.J. (2004). Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics3, 133—44.
117.
Melle, C., Kaufmann, R., Hommann, M., Bleul, A., Driesch, D., Ernst, G., and von Eggeling, F. (2004). Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology . Int J Oncol24, 885—91.
118.
Meneses-Lorente, G., Guest, P.C., Lawrence, J., Muniappa, N., Knowles, M.R., Skynner, H.A., Salim, K., Cristea, I., Mortishire-Smith, R., Gaskell, S.J., and Watt, A. (2004). A proteomic investigation of drug-induced steatosis in rat liver. Chem Res Toxicol17, 605—12.
119.
Merrick, B.A. (2003). The human proteome organization (HUPO) and environmental health. EHP Toxicogenomics111, 1—5.
120.
Merrick, B.A. (2004). Introduction to high-throughput protein expression . In Toxicogenomics: Principles and Applications (H. K. Hamadeh and C. A. Afshari , eds.), pp. 263—81. Wiley and Sons, Inc., New York.
121.
Merrick, B.A., and Tomer, K.B. (2003). Toxicoproteomics: a parallel approach to identifying biomarkers. Environ Health Perspect111, A578—9.
122.
Michnick, S.W. (2004). Proteomics in living cells. Drug Discov Today9, 262— 7.
123.
Mikhailov, A., Harmala-Brasken, A.S., Hellman, J., Meriluoto, J., and Eriksson, J.E. (2003). Identification of ATP-synthase as a novel intracellular target for microcystin-LR. Chem Biol Interact142, 223—37.
124.
Moller, A., Soldan, M., Volker, U., and Maser, E. (2001). Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. Toxicology160, 129—38.
125.
Mootha, V.K., Bunkenborg, J., Olsen, J.V., Hjerrild, M., Wisniewski, J.R., Stahl, E., Bolouri, M.S., Ray, H.N., Sihag, S., Kamal, M., Patterson, N., Lander, E.S., and Mann, M. (2003). Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell115, 629—40.
126.
Nerland, D.E., Cai, J., and Benz, F.W. (2003). Selective covalent binding of acrylonitrile to Cys 186 in rat liver carbonic anhydrase III in vivo. Chem Res Toxicol16, 583—9.
127.
Nesvizhskii, A.I., and Aebersold, R. (2004). Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS. Drug Discov Today9, 173—81.
128.
Nuwaysir, E.F., Bittner, M., Trent, J., Barrett, J.C., and Afshari, C.A. (1999). Microarrays and toxicology: the advent of toxicogenomics . Mol Carcinog24, 153—9.
129.
Oda, Y., Owa, T., Sato, T., Boucher, B., Daniels, S., Yamanaka, H., Shinohara, Y., Yokoi, A., Kuromitsu, J., and Nagasu, T. (2003). Quantitative chemical proteomics for identifying candidate drug targets. Anal Chem75, 2159—65.
130.
O'Farrell, P.H. (1975). High resolution two-dimensional electrophoresis of proteins. J Biol Chem250, 4007—21.
131.
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K.M., Carver, L.A., Testa, J.E., and Schnitzer, J.E. (2004). Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature429, 629—35.
132.
O'Neill, E.E., Brock, C.J., von Kriegsheim, A.F., Pearce, A.C., Dwek, R.A., Watson, S.P., and Hebestreit, H.F. (2002). Towards complete analysis of the platelet proteomeProteomics2, 288—305.
133.
Ong, S.E., and Pandey, A. (2001). An evaluation of the use of two-dimensional gel electrophoresis in proteomics. Biomol Eng18, 195—205.
134.
Orchard, S., Hermjakob, H., Julian, R.K., Jr., Runte, K., Sherman, D., Wojcik, J., Zhu, W., and Apweiler, R. (2004). Common interchange standards for proteomics data: public availability of tools and schema. Proteomics4, 490—1.
135.
Ornstein, D.K., and Petricoin, E.F., 3rd. (2004). Proteomics to diagnose human tumors and provide prognostic information. Oncology (Huntingt)18, 521— 9; discussion 529—32.
136.
Patterson, S.D. (2003). Proteomics: evolution of the technology. Biotechniques35, 440—4.
137.
Paweletz, C.P., Charboneau, L., Bichsel, V.E., Simone, N.L., Chen, T., Gillespie, J.W., Emmert-Buck, M.R., Roth, M.J., Petricoin, I.E., and Liotta, L.A. (2001). Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene20, 1981—9.
138.
Pelech, S. (2004). Tracking cell signaling protein expression and phosphorylation by innovative proteomic solutions. Curr Pharm Biotechnol5, 69—77.
139.
Pennisi, E. (2003). Human genome. A low number wins the GeneSweep Pool. Science300, 1484.
140.
Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., and Liotta, L.A. (2002). Use of proteomic patterns in serum to identify ovarian cancer. Lancet359, 572—7.
141.
Petricoin, E.F., and Liotta, L.A. (2004). SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol15, 24—30.
142.
Pieper, R., Gatlin, C.L., Makusky, A.J., Russo, P.S., Schatz, C.R., Miller, S.S., Su, Q., McGrath, A.M., Estock, M.A., Parmar, P.P., Zhao, M., Huang, S.T., Zhou, J., Wang, F., Esquer-Blasco, R., Anderson, N.L., Taylor, J., and Steiner, S. (2003a). The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics3, 1345—64.
143.
Pieper, R., Gatlin, C.L., McGrath, A.M., Makusky, A.J., Mondal, M., Seonarain, M., Field, E., Schatz, C.R., Estock, M.A., Ahmed, N., Anderson, N.G., and Steiner, S. (2004). Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics4, 1159—74.
144.
Pieper, R., Su, Q., Gatlin, C.L., Huang, S.T., Anderson, N.L., and Steiner, S. (2003b). Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome . Proteomics3, 422—32.
145.
Ping, P. (2003). Identification of novel signaling complexes by functional proteomics. Circ Res93, 595—603.
146.
Poon, T.C., Yip, T.T., Chan, A.T., Yip, C., Yip, V., Mok, T.S., Lee, C.C., Leung, T.W., Ho, S.K., and Johnson, P.J. (2003). Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes . Clin Chem49, 752— 60.
147.
Puchades, M., Hansson, S.F., Nilsson, C.L., Andreasen, N., Blennow, K., and Davidsson, P. (2003). Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res118, 140—6.
148.
Qian, W.J., Goshe, M.B., Camp, D.G., 2nd, Yu, L.R., Tang, K., and Smith, R.D. (2003). Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures . Anal Chem75, 5441—50.
149.
Ranish, J.A., Yi, E.C., Leslie, D.M., Purvine, S.O., Goodlett, D.R., Eng, J., and Aebersold, R. (2003). The study of macromolecular complexes by quantitative proteomics. Nat Genet33, 349—55.
150.
Resing, K.A. (2002). Analysis of signaling pathways using functional proteomics. Ann NY Acad Sci971, 608—14.
151.
Roberts, R., Cain, K., Coyle, B., Freathy, C., Leonard, J.F., and Gautier, J.C. (2003). Early drug safety evaluation: biomarkers, signatures, and fingerprints. Drug Metab Rev35, 269—75.
152.
Robinson, W.H., Steinman, L., and Utz, P.J. (2002). Protein and peptide array analysis of autoimmune diseaseBiotechniques (Suppl), 66—9.
153.
Rosenblatt, K.P., Bryant-Greenwood, P., Killian, J.K., Mehta, A., Geho, D., Espina, V., Petricoin, E.F., 3rd , and Liotta, L.A. (2004). Serum proteomics in cancer diagnosis and management. Annu Rev Med55, 97—112.
154.
Rosty, C., Christa, L., Kuzdzal, S., Baldwin, W.M., Zahurak, M.L., Carnot, F., Chan, D.W., Canto, M., Lillemoe, K.D., Cameron, J.L., Yeo, C.J., Hruban, R.H., and Goggins, M. (2002). Identification ofhepatocarcinomaintestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res62, 1868—75.
155.
Rouquette, A.M., Desgruelles, C., and Laroche, P. (2003). Evaluation of the new multiplexed immunoassay, FIDIS, for simultaneous quantitative determination of antinuclear antibodies and comparison with conventional methods. Am J Clin Pathol120, 676—81.
156.
Ruepp, S.U., Tonge, R.P., Shaw, J., Wallis, N., and Pognan, F. (2002). Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci65, 135—50.
157.
Sam-Yellowe, T.Y., Florens, L., Johnson, J.R., Wang, T., Drazba, J.A., Le Roch, K.G., Zhou, Y., Batalov, S., Carucci, D.J., Winzeler, E.A., and Yates, J.R., 3rd. (2004). A plasmodium gene family encoding Maurer's cleft membrane proteins: structural properties and expression profiling . Genome Res14, 1052—9.
158.
Sanchez, C., Lachaize, C., Janody, F., Bellon, B., Roder, L., Euzenat, J., Rechenmann, F., and Jacq, B. (1999). Grasping at molecular interactions and genetic networks in Drosophila melanogaster using FlyNets, an Internet database. Nucleic Acids Res27, 89—94.
159.
Scheele, G.A. (1975). Two-dimensional gel analysis of soluble proteins. Characterization of guinea pig exocrine pancreatic proteins. J Biol Chem250, 5375—85.
160.
Scherl, A., Francois, P., Converset, V., Bento, M., Burgess, J.A., Sanchez, J.C., Hochstrasser, D.F., Schrenzel, J., and Corthals, G.L. (2004). Nonredundant mass spectrometry: a strategy to integrate mass spectrometry acquisition and analysis. Proteomics4, 917—27.
161.
Schirmer, E.C., Florens, L., Guan, T., Yates, J.R., 3rd, and Gerace, L. (2003). Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science301, 1380—2.
162.
Schweitzer, B., Roberts, S., Grimwade, B., Shao, W., Wang, M., Fu, Q., Shu, Q., Laroche, I., Zhou, Z., Tchernev, V.T., Christiansen, J., Velleca, M., and Kingsmore, S.F. (2002). Multiplexed protein profiling on microarrays by rolling-circle amplification. Nat Biotechnol20, 359—65.
163.
Shabalina, S.A., and Spiridonov, N.A. (2004). The mammalian transcriptome and the function of non-coding DNA sequences. Genome Biol5, 105.
164.
Sharma, R., Komatsu, S., and Noda, H. (2004). Proteomic analysis of brown planthopper: application to the study of carbamate toxicity. Insect Biochem Mol Biol34, 425—32.
Shepard, J.L., Olsson, B., Tedengren, M., and Bradley, B.P. (2000). Protein expression signatures identified in Mytilus edulis exposed to PCBs, copper and salinity stress. Mar Environ Res50, 337—40.
167.
Shi, M.M. (2002). Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes. Am J Pharmacogenomics2, 197—205.
168.
Shrader, E.A., Henry, T.R., Greeley, M.S., Jr., and Bradley, B.P. (2003). Proteomics in zebrafish exposed to endocrine disrupting chemicals. Ecotoxicology12, 485—8.
169.
Son, W.K., Lee, D.Y., Lee, S.H., Joo, W.A., and Kim, C.W. (2003). Analysis of proteins expressed in rat plasma exposed to dioxin using 2-dimensional gel electrophoresis. Proteomics3, 2393—401.
170.
Sorensen, M., Autrup, H., Moller, P., Hertel, O., Jensen, S.S., Vinzents, P., Knudsen, L.E., and Loft, S. (2003). Linking exposure to environmental pollutants with biological effects. Mutat Res544, 255—71.
171.
Southan, C. (2004). Has the yo-yo stopped? An assessment of human protein-coding gene number. Proteomics4, 1712—26.
172.
Steiner, S., Gatlin, C.L., Lennon, J.J., McGrath, A.M., Seonarain, M.D., Makusky, A.J., Aponte, A.M., Esquer-Blasco, R., and Anderson, N.L. (2001). Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin. Toxicol Lett120, 369—77.
173.
Steinhauer, C., Wingren, C., Hager, A.C., and Borrebaeck, C.A. (2002). Single framework recombinant antibody fragments designed for protein chip applicationsBiotechniques (Suppl), 38—45.
174.
Storck, T., von Brevern, M.C., Behrens, C.K., Scheel, J., and Bach, A. (2002). Transcriptomics in predictive toxicologyCurr Opin Drug Discov Devel5, 90—7.
175.
Stulik, J., Hernychova, L., Porkertova, S., Pozler, O., Tuckova, L., Sanchez, D., and Bures, J. (2003). Identification of new celiac disease autoantigens using proteomic analysis. Proteomics3, 951—6.
176.
Suter, L., Babiss, L.E., and Wheeldon, E.B. (2004). Toxicogenomics in predictive toxicology in drug development. Chem Biol11, 161—71.
177.
Takahashi, N., Kaji, H., Yanagida, M., Hayano, T., and Isobe, T. (2003). Proteomics: advanced technology for the analysis of cellular function. J Nutr133, 2090S—2096S.
178.
Tirumalai, R.S., Chan, K.C., Prieto, D.A., Issaq, H.J., Conrads, T.P., and Veenstra, T.D. (2003). Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics2, 1096—103.
179.
Tong, W., Cao, X., Harris, S., Sun, H., Fang, H., Fuscoe, J., Harris, A., Hong, H., Xie, Q., Perkins, R., Shi, L., and Casciano, D. (2003). ArrayTrack— supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. Environ Health Perspect111, 1819—26.
180.
Tonge, R., Shaw, J., Middleton, B., Rowlinson, R., Rayner, S., Young, J., Pognan, F., Hawkins, E., Currie, I., and Davison, M. (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics1, 377—96.
181.
Toussaint, O., Dumont, P., Dierick, J.F., Pascal, T., Frippiat, C., Chainiaux, F., Magalhaes, J.P., Eliaers, F., and Remacle, J. (2000). Stress-induced premature senescence as alternative toxicological method for testing the long-term effects of molecules under development in the industry. Biogerontology1, 179—83.
182.
van Ommen, B., and Stierum, R. (2002). Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol13, 517— 21.
183.
Veenstra, T.D., and Conrads, T.P. (2003). Serum protein fingerprinting. Curr Opin Mol Ther5, 584—93.
184.
Venkatraman, A., Landar, A., Davis, A.J., Ulasova, E., Page, G., Murphy, M.P., Darley-Usmar, V., and Bailey, S.M. (2004). Oxidative modification of hepatic mitochondria protein thiols: effect of chronic alcohol consumption. Am J Physiol Gastrointest Liver Physiol286, G521—7.
185.
Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., Gocayne, J.D., Amanatides, P., Ballew, R.M., Huson, D.H., Wortman, J.R., Zhang, Q., Kodira, C.D., Zheng, X.H., Chen, L., Skupski, M., Subramanian, G., Thomas, P.D., Zhang, J., Gabor Miklos, G.L., Nelson, C., Broder, S., Clark, A.G., Nadeau, J., McKusick, V.A., Zinder, N., Levine, A.J., Roberts, R.J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eilbeck, K., Evangelista, C., Gabrielian, A.E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T.J., Higgins, M.E., Ji, R.R., Ke, Z., Ketchum, K.A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G.V., Milshina, N., Moore, H.M., Naik, A.K., Narayan, V.A., Neelam, B., Nusskern, D., Rusch, D.B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., Yao, A., Ye, J., Zhan, M., Zhang, W., Zhang, H., Zhao, Q., Zheng, L., Zhong, F., Zhong, W., Zhu, S., Zhao, S., Gilbert, D., Baumhueter, S., Spier, G., Carter, C., Cravchik, A., Woodage, T., Ali, F., An, H., Awe, A., Baldwin, D., Baden, H., Barnstead, M., Barrow, I., Beeson, K., Busam, D., Carver, A., Center, A., Cheng, M.L., Curry, L., Danaher, S., Davenport, L., Desilets, R., Dietz, S., Dodson, K., Doup, L., Ferriera, S., Garg, N., Gluecksmann, A., Hart, B., Haynes, J., Haynes, C., Heiner, C., Hladun, S., Hostin, D., Houck, J., Howland, T., Ibegwam, C., Johnson, J., Kalush, F., Kline, L., Koduru, S., Love, A., Mann, F., May, D., McCawley, S., McIntosh, T., McMullen, I., Moy, M., Moy, L., Murphy, B., Nelson, K., Pfannkoch, C., Pratts, E., Puri, V., Qureshi, H., Reardon, M., Rodriguez, R., Rogers, Y.H., Romblad, D., Ruhfel, B., Scott, R., Sitter, C., Smallwood, M., Stewart, E., Strong, R., Suh, E., Thomas, R., Tint, N.N., Tse, S., Vech, C., Wang, G., Wetter, J., Williams, S., Williams, M., Windsor, S., Winn-Deen, E., Wolfe, K., Zaveri, J., Zaveri, K., Abril, J.F., Guigo, R., Campbell, M.J., Sjolander, K.V., Karlak, B., Kejariwal, A., Mi, H., Lazareva, B., Hatton, T., Narechania, A., Diemer, K., Muruganujan, A., Guo, N., Sato, S., Bafna, V., Istrail, S., Lippert, R., Schwartz, R., Walenz, B., Yooseph, S., Allen, D., Basu, A., Baxendale, J., Blick, L., Caminha, M., Carnes-Stine, J., Caulk, P., Chiang, Y.H., Coyne, M., Dahlke, C., Mays, A., Dombroski, M., Donnelly, M., Ely, D., Esparham, S., Fosler, C., Gire, H., Glanowski, S., Glasser, K., Glodek, A., Gorokhov, M., Graham, K., Gropman, B., Harris, M., Heil, J., Henderson, S., Hoover, J., Jennings, D., Jordan, C., Jordan, J., Kasha, J., Kagan, L., Kraft, C., Levitsky, A., Lewis, M., Liu, X., Lopez, J., Ma, D., Majoros, W., McDaniel, J., Murphy, S., Newman, M., Nguyen, T., Nguyen, N., Nodell, M., Pan, S., Peck, J., Peterson, M., Rowe, W., Sanders, R., Scott, J., Simpson, M., Smith, T., Sprague, A., Stockwell, T., Turner, R., Venter, E., Wang, M., Wen, M., Wu, D., Wu, M., Xia, A., Zandieh, A., and Zhu, X. (2001). The sequence of the human genomeScience291, 1304—51.
186.
Vido, K., Spector, D., Lagniel, G., Lopez, S., Toledano, M.B., and Labarre, J. (2001). A proteome analysis of the cadmium response in Saccharomyces cerevisiae. J Biol Chem276, 8469—74.
187.
Villanueva, J., Philip, J., Entenberg, D., Chaparro, C.A., Tanwar, M.K., Holland, E.C., and Tempst, P. (2004). Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal Chem76, 1560—70.
188.
Vitorino, R., Lobo, M.J., Ferrer-Correira, A.J., Dubin, J.R., Tomer, K.B., Domingues, P.M., and Amado, F.M. (2004). Identification of human whole saliva protein components using proteomics. Proteomics4, 1109— 15.
189.
Vlahou, A., Laronga, C., Wilson, L., Gregory, B., Fournier, K., McGaughey, D., Perry, R.R., Wright, G.L., Jr., and Semmes, O.J. (2003). A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer4, 203—9.
190.
Von Haller, P.D., Yi, E., Donohoe, S., Vaughn, K., Keller, A., Nesvizhskii, A.I., Eng, J., Li, X.J., Goodlett, D.R., Aebersold, R., and Watts, J.D. (2003). The application of new software tools to quantitative protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry: I. Statistically annotated datasets for peptide sequences and proteins identified via the application of ICAT and tandem mass spectrometry to proteins copurifying with T cell lipid rafts. Mol Cell Proteomics2, 426— 7.
191.
Walgren, J.L., and Thompson, D.C. (2004). Application of proteomic technologies in the drug development process. Toxicol Lett149, 377—85.
192.
Wallace, K.B., Hausner, E., Herman, E., Holt, G.D., MacGregor, J.T., Metz, A.L., Murphy, E., Rosenblum, I.Y., Sistare, F.D., and York, M.J. (2004). Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol Pathol32, 106—21.
193.
Washburn, M.P., Koller, A., Oshiro, G., Ulaszek, R.R., Plouffe, D., Deciu, C., Winzeler, E., and Yates, J.R., 3rd. (2003a). Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae . Proc Natl Acad Sci USA100, 3107—12.
194.
Washburn, M.P., Ulaszek, R.R., and Yates, J.R., 3rd. (2003b). Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem75, 5054—61.
195.
Waters, M., Boorman, G., Bushel, P., Cunningham, M., Irwin, R., Merrick, A., Olden, K., Paules, R., Selkirk, J., Stasiewicz, S., Weis, B., Van Houten, B., Walker, N., and Tennant, R. (2003a). Systems toxicology and the chemical effects in biological systems (CEBS) knowledge base. EHP Toxicogenomics111, 15—28.
196.
Waters, M.D., Olden, K., and Tennant, R.W. (2003b). Toxicogenomic approach for assessing toxicant-related disease. Mutat Res544, 415—24.
197.
Wattiez, R., Noel-Georis, I., Cruyt, C., Broeckaert, F., Bernard, A., and Falmagne, P. (2003). Susceptibility to oxidative stress: proteomic analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of miceProteomics3, 658—65.
198.
Weigl, B.H., Bardell, R.L., and Cabrera, C.R. (2003). Lab-on-a-chip for drug development. Adv Drug Deliv Rev55, 349—77.
199.
Weinreb, O., Mandel, S., and Youdim, M.B. (2003). cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cellsFaseb J17, 935—7.
200.
Wen, S.Y., Wang, H., Sun, O.J., and Wang, S.Q. (2003). Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray. World J Gastroenterol9, 1342—6.
201.
Westbrook, J.A., Yan, J.X., Wait, R., Welson, S.Y., and Dunn, M.J. (2001). Zooming in on the proteome: very narrow-range immobilised pH gradients reveal more protein species and isoforms. Electrophoresis22, 2865— 71.
202.
Wheelock, A.M., Zhang, L., Tran, M.U., Morin, D., Penn, S., Buckpitt, A.R., andPlopper, C.G. (2004). Isolation of rodent airway epithelial cell proteins facilitates in vivo proteomics studies of lung toxicity. Am J Physiol Lung Cell Mol Physiol286, L399—410.
203.
Wilkins, M.R., Sanchez, J.C., Gooley, A.A., Appel, R.D., Humphery-Smith, I., Hochstrasser, D.F., and Williams, K.L. (1996). Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotechnol Genet Eng Rev13, 19—50.
204.
Williams, D.M., and Cole, P.A. (2001). Kinase chips hit the proteomics era. Trends Biochem Sci26, 271—3.
205.
Witzmann, F.A., Bauer, M.D., Fieno, A.M., Grant, R.A., Keough, T.W., Kornguth, S.E., Lacey, M.P., Siegel, F.L., Sun, Y., Wright, L.S., Young, R.S., and Witten, M.L. (1999). Proteomic analysis of simulated occupational jet fuel exposure in the lung. Electrophoresis20, 3659—69.
206.
Witzmann, F.A., Bauer, M.D., Fieno, A.M., Grant, R.A., Keough, T.W., Lacey, M.P., Sun, Y., Witten, M.L., and Young, R.S. (2000a). Proteomic analysis of the renal effects of simulated occupational jet fuel exposure. Electrophoresis21, 976—84.
207.
Witzmann, F.A., Bobb, A., Briggs, G.B., Coppage, H.N., Hess, R.A., Li, J., Pedrick, N.M., Ritchie, G.D., Iii, J.R., and Still, K.R. (2003). Analysis of rat testicular protein expression following 91-day exposure to JP-8 jet fuel vapor. Proteomics3, 1016—27.
208.
Witzmann, F.A., Carpenter, R.L., Ritchie, G.D., Wilson, C.L., Nordholm, A.F., and Rossi, J., 3rd. (2000b). Toxicity of chemical mixtures: proteomic analysis of persisting liver and kidney protein alterations induced by repeated exposure of rats to JP-8 jet fuel vaporElectrophoresis21, 2138—47.
209.
Witzmann, F.A., and Li, J. (2002). Cutting-edge technology. II. Proteomics: core technologies and applications in physiology. Am J Physiol Gastrointest Liver Physiol282, G735—41.
210.
Wolters, D.A., Washburn, M.P., and Yates, J.R., 3rd. (2001). An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem73, 5683—90.
211.
Wright, G.L., Jr. (2002). SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn2, 549—63.
Wu, P., and Grainger, D.W. (2004). Toward immobilized antibody microarray optimization: print buffer and storage condition comparisons on performance. Biomed Sci Instrum40, 243—8.
214.
Xiao, X., Liu, D., Tang, Y., Guo, F., Xia, L., Liu, J., and He, D. (2003). Development of proteomic patterns for detecting lung cancer. Dis Markers19, 33—9.
215.
Xirasagar, S., Gustafson, S., Merrick, B.A., Tomer, K.B., Stasiewicz, S., Chan, D.D., Yost, K.J., 3rd, Yates, J.R., 3rd, Sumner, S., Xiao, N., and Waters, M.D. (2004). CEBS object model for systems biology data, SysBio-OMBioinformatics, in press.
216.
Yan, J.X., Devenish, A.T., Wait, R., Stone, T., Lewis, S., and Fowler, S. (2002). Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics2, 1682—98.
217.
Yates, J.R. (2004). Mass spectral analysis in proteomics. Annu Rev Biophys Biomol Struct33, 297—316.
218.
Zha, H., Raffeld, M., Charboneau, L., Pittaluga, S., Kwak, L.W., Petricoin, E., 3rd, Liotta, L.A., and Jaffe, E.S. (2004). Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest84, 235—44.
219.
Zhang, Y., Champagne, N., Beitel, L.K., Goodyer, C.G., Trifiro, M., and LeBlanc, A. (2004). Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J Neurosci24, 5315—21.
220.
Zhou, G., Li, H., DeCamp, D., Chen, S., Shu, H., Gong, Y., Flaig, M., Gillespie, J.W., Hu, N., Taylor, P.R., Emmert-Buck, M.R., Liotta, L.A., Petricoin, E.F., 3rd , and Zhao, Y. (2002). 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics1, 117—24.
221.
Zhou, M., and Yu, L.R. (2003). Proteomic analysis by two-dimensional polyacrylamide gel electrophoresis. Adv Protein Chem65, 57—84.
222.
Zhu, H., Bilgin, M., and Snyder, M. (2003). Proteomics. Annu Rev Biochem72, 783—812.
223.
Zhukov, T.A., Johanson, R.A., Cantor, A.B., Clark, R.A., and Tockman, M.S. (2003). Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry . Lung Cancer40, 267—79.
